NL189999C - Farmaceutisch preparaat met werkzaamheid tegen tumoren. - Google Patents

Farmaceutisch preparaat met werkzaamheid tegen tumoren.

Info

Publication number
NL189999C
NL189999C NLAANVRAGE8001045,A NL8001045A NL189999C NL 189999 C NL189999 C NL 189999C NL 8001045 A NL8001045 A NL 8001045A NL 189999 C NL189999 C NL 189999C
Authority
NL
Netherlands
Prior art keywords
tumors
effect
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
NLAANVRAGE8001045,A
Other languages
English (en)
Dutch (nl)
Other versions
NL189999B (nl
NL8001045A (nl
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of NL8001045A publication Critical patent/NL8001045A/nl
Publication of NL189999B publication Critical patent/NL189999B/xx
Application granted granted Critical
Publication of NL189999C publication Critical patent/NL189999C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NLAANVRAGE8001045,A 1979-02-27 1980-02-20 Farmaceutisch preparaat met werkzaamheid tegen tumoren. NL189999C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent
JP2133979 1979-02-27

Publications (3)

Publication Number Publication Date
NL8001045A NL8001045A (nl) 1980-08-29
NL189999B NL189999B (nl) 1993-05-03
NL189999C true NL189999C (nl) 1993-10-01

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8001045,A NL189999C (nl) 1979-02-27 1980-02-20 Farmaceutisch preparaat met werkzaamheid tegen tumoren.

Country Status (12)

Country Link
US (1) US4347240A (fr)
JP (1) JPS55113718A (fr)
BR (1) BR8001129A (fr)
CA (1) CA1124176A (fr)
CH (1) CH653556A5 (fr)
DE (1) DE3007412A1 (fr)
FR (1) FR2450108B1 (fr)
HK (1) HK23784A (fr)
IT (1) IT1129802B (fr)
MY (1) MY8500010A (fr)
NL (1) NL189999C (fr)
SG (1) SG38183G (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
WO1994026114A1 (fr) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Procede de stimulation et de modulation du systeme immunitaire d'animaux a l'aide de compositions microbiennes
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
WO1997049820A1 (fr) 1996-06-26 1997-12-31 Kabushiki Kaisha Yakult Honsha Procedes de transfert de genes dans un chromosome
MXPA99007378A (es) * 1997-02-11 2005-04-19 Entpr Ireland Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas.
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
EP1631308B1 (fr) * 2003-05-30 2013-07-31 Amylin Pharmaceuticals, LLC Nouveaux procedes et nouvelles compositions pour une administration amelioree par voie muqueuse de peptides et de proteines
ATE442154T1 (de) * 2003-07-30 2009-09-15 Bhph Company Ltd Neues lactobacillus, den lebenden kírper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden kírpers
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
JP5401733B2 (ja) * 2005-02-11 2014-01-29 バイオラクティス インコーポレイティド プロバイオティクス及びシンバイオティックとしてのラクトバチルス・ケフィラノファシエンス（Ｌａｃｔｏｂａｃｉｌｌｕｓｋｅｆｉｒａｎｏｆａｃｉｅｎｓ）の使用
EP2075332B1 (fr) * 2006-10-27 2014-04-16 Kabushiki Kaisha Yakult Honsha Gène régulateur de la production de cytokines et utilisation de celui-ci
US20100068184A1 (en) * 2006-11-02 2010-03-18 Aureo Co., Ltd. Living body healing accelerator
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
EP2498789B1 (fr) 2009-11-11 2016-06-22 Alimentary Health Limited Souche de bifidobacterium probiotique
ES2610829T3 (es) 2009-11-11 2017-05-03 Alimentary Health Limited Cepa de Bifidobacterium
EP3589726A1 (fr) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum apte à moduler de manière bénéfique une réponse immunitaire à l'encontre d'une infection virale respiratoire
WO2018172537A1 (fr) 2017-03-23 2018-09-27 Universiteit Antwerpen Nouvelle souche de lactobacillus casei probiotique et ses utilisations
WO2021180973A1 (fr) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
NL189999B (nl) 1993-05-03
JPS55113718A (en) 1980-09-02
FR2450108A1 (fr) 1980-09-26
HK23784A (en) 1984-03-23
CA1124176A (fr) 1982-05-25
IT1129802B (it) 1986-06-11
FR2450108B1 (fr) 1988-10-28
NL8001045A (nl) 1980-08-29
DE3007412A1 (de) 1980-11-06
US4347240A (en) 1982-08-31
MY8500010A (en) 1985-12-31
IT8067302A0 (it) 1980-02-27
CH653556A5 (de) 1986-01-15
SG38183G (en) 1984-07-20
BR8001129A (pt) 1980-11-04
JPS6234727B2 (fr) 1987-07-28

Similar Documents

Publication Publication Date Title
NL189999C (nl) Farmaceutisch preparaat met werkzaamheid tegen tumoren.
NL180632C (nl) Antitranspiratiepreparaat.
NO801863L (no) Farmasoeytiske preparater.
FI850198A0 (fi) Expressionsplasmid.
ES256673Y (es) Guardavistas.
NO803313L (no) Tablett.
ES254327Y (es) Portillon.
FI73548B (fi) Oeverstroemskyddskrets foer effekttransistor.
FI73539B (fi) Multiplexanslutningsenhet foer en digitalstation.
NL7805158A (nl) Farmaceutisch preparaat.
NL7705560A (nl) Farmaceutisch preparaat.
NL7812344A (nl) Farmaceutisch preparaat.
NL7712100A (nl) Farmaceutische preparaten.
NL7805504A (nl) Farmaceutische preparaat.
FI803048A7 (fi) Vaimennin-perälaatikkoliitäntä.
ES243147Y (es) Expositor perfeccionado.
ES242777Y (es) Expositor perfeccionado.
ES243057Y (es) Cubierto perfeccionado.
ES242279Y (es) Pupitre perfeccionado.
ES243015Y (es) Caja-envase perfeccionada.
ES244184Y (es) Somier perfeccionado.
ES242291Y (es) Inflamador perfeccionado.
ES240647Y (es) Pala-recogedor perfeccionada.
ES242747Y (es) Mesa-revistero perfeccionada.
ES242651Y (es) Cama-somier perfeccionada.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20000220